These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6493038)

  • 21. The mouse osteopetrotic grey-lethal mutation induces a defect in osteoclast maturation/function.
    Rajapurohitam V; Chalhoub N; Benachenhou N; Neff L; Baron R; Vacher J
    Bone; 2001 May; 28(5):513-23. PubMed ID: 11344051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of congenital osteopetrosis in the rabbit with high-dose 1,25-dihydroxyvitamin D.
    Popoff SN; McGuire JL; Zerwekh JE; Marks SC
    J Bone Miner Res; 1989 Feb; 4(1):57-67. PubMed ID: 2718779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent developments in the understanding of the pathophysiology of osteopetrosis.
    Felix R; Hofstetter W; Cecchini MG
    Eur J Endocrinol; 1996 Feb; 134(2):143-56. PubMed ID: 8630510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period.
    Boyce RW; Varela A; Chouinard L; Bussiere JL; Chellman GJ; Ominsky MS; Pyrah IT
    Bone; 2014 Jul; 64():314-25. PubMed ID: 24727159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of bone mass and osteoclast function depend on the F-actin modulator SWAP-70.
    Garbe AI; Roscher A; Schüler C; Lutter AH; Glösmann M; Bernhardt R; Chopin M; Hempel U; Hofbauer LC; Rammelt S; Egerbacher M; Erben RG; Jessberger R
    J Bone Miner Res; 2012 Oct; 27(10):2085-96. PubMed ID: 22648978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphological evidence of reduced bone resorption in the osteosclerotic (oc) mouse.
    Seifert MF; Marks SC
    Am J Anat; 1985 Feb; 172(2):141-53. PubMed ID: 3976544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced life span of the osteoclast in osteopetrotic (mi and midi) mice.
    Marshall MJ; Rees JA; Nisbet NW; Wiseman J
    Bone Miner; 1987 Apr; 2(2):115-24. PubMed ID: 3504723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrophage colony-stimulating factor and receptor activator NF-kappaB ligand fail to rescue osteoclast-poor human malignant infantile osteopetrosis in vitro.
    Flanagan AM; Massey HM; Wilson C; Vellodi A; Horton MA; Steward CG
    Bone; 2002 Jan; 30(1):85-90. PubMed ID: 11792569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limited rescue of osteoclast-poor osteopetrosis after successful engraftment by cord blood from an unrelated donor.
    Nicholls BM; Bredius RG; Hamdy NA; Gerritsen EJ; Lankester AC; Hogendoorn PC; Nesbitt SA; Horton MA; Flanagan AM
    J Bone Miner Res; 2005 Dec; 20(12):2264-70. PubMed ID: 16294279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skeletal biology in the toothless (osteopetrotic) rat.
    Seifert MF; Popoff SN; Marks SC
    Am J Anat; 1988 Oct; 183(2):158-65. PubMed ID: 3202082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteopetrosis in the toothless (t1) rat: presence of osteoclasts but failure to respond to parathyroid extract or to be cured by infusion of spleen or bone marrow cells from normal littermates.
    Marks SC
    Am J Anat; 1977 Jun; 149(2):289-97. PubMed ID: 327788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The V-ATPase a3 subunit mutation R740S is dominant negative and results in osteopetrosis in mice.
    Ochotny N; Flenniken AM; Owen C; Voronov I; Zirngibl RA; Osborne LR; Henderson JE; Adamson SL; Rossant J; Manolson MF; Aubin JE
    J Bone Miner Res; 2011 Jul; 26(7):1484-93. PubMed ID: 21305608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defective osteoclast differentiation and function in the osteopetrotic (os) rabbit.
    Lenhard S; Popoff SN; Marks SC
    Am J Anat; 1990 Aug; 188(4):438-44. PubMed ID: 2393000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteopetrosis in the toothless rat: failure of osteoclast differentiation and function.
    Osier LK; Popoff SN; Marks SC
    Bone Miner; 1987 Oct; 3(1):35-45. PubMed ID: 3505191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skeletal resistance to 1,25-dihydroxyvitamin D3 in osteopetrotic rats.
    Safadi FF; Hermey DC; Popoff SN; Seifert MF
    Endocrine; 1999 Dec; 11(3):309-19. PubMed ID: 10786828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of bone resorption by hematopoietic tissue. The induction and reversal of congenital osteopetrosis in mice through use of bone marrow and splenic transplants.
    Walker DG
    J Exp Med; 1975 Sep; 142(3):651-63. PubMed ID: 1100763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of the nonresorptive phenotype of osteoclast-like cells from patients with malignant osteopetrosis: a new approach to investigating pathogenesis.
    Flanagan AM; Sarma U; Steward CG; Vellodi A; Horton MA
    J Bone Miner Res; 2000 Feb; 15(2):352-60. PubMed ID: 10703938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of bone and parathyroid hormone as stimulators of osteoclast development and activity in calvarial cell cultures from normal and osteopetrotic (mi/mi) mice.
    Graves L; Jilka RL
    J Cell Physiol; 1990 Oct; 145(1):102-9. PubMed ID: 2211836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formation of non-resorbing osteoclasts from peripheral blood mononuclear cells of patients with malignant juvenile osteopetrosis.
    Helfrich MH; Gerritsen EJ
    Br J Haematol; 2001 Jan; 112(1):64-8. PubMed ID: 11167785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1.
    Tondravi MM; McKercher SR; Anderson K; Erdmann JM; Quiroz M; Maki R; Teitelbaum SL
    Nature; 1997 Mar; 386(6620):81-4. PubMed ID: 9052784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.